Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-047937

Chief Executive Officer sold 7,800 shares at an average $36.37 ($283,647)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-08-20 Sale : show line 1 in the form −3,900 $36.04 $140,556 78,178 I
2018-08-21 Sale : show line 2 in the form −3,900 $36.69 $143,091 74,278 I
Open-market sales · 7,800 sh · avg $36.37 · $283,647
Loading xslF345X03/doc4.xml…